We have developed a series of advanced vector systems with applications in producing standard monoclonal antibodies, antibody-drug conjugates as well as more complex and difficult to express molecules such as bi-specific antibodies. Each component has been optimized to work together, so our vector systems will be supported by selected host cell lines, media and feeds.
